Deepti Radia, MBBS, BSc, MRCPI, FRCPath, MSc Med Ed

Deepti Radia, MBBS, BSc, MRCPI, FRCPath, MSc Med Ed, overviews the phase 3 HARBOR trial evaluating elenestinib in indolent systemic mastocytosis.

Deepti Radia, MBBS, BSc, MRCPI, FRCPath, MSc Med Ed, discusses long-term data from avapritinib in advanced systemic mastocytosis from the PATHFINDER trial.